Involved panellists reached a consensus in considering PSMA-targeted PET/CT the preferred staging and restaging imaging modality for oligometastatic, oligorecurrent, and oligoprogressive PCa [17]. This evidence concerns the gene FOLH1 and posterior cortical atrophy.